Correlation Between Chevron Corp and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Chevron Corp and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chevron Corp and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chevron Corp and Kymera Therapeutics, you can compare the effects of market volatilities on Chevron Corp and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chevron Corp with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chevron Corp and Kymera Therapeutics.
Diversification Opportunities for Chevron Corp and Kymera Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Chevron and Kymera is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Chevron Corp and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Chevron Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chevron Corp are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Chevron Corp i.e., Chevron Corp and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Chevron Corp and Kymera Therapeutics
Considering the 90-day investment horizon Chevron Corp is expected to generate 9.03 times less return on investment than Kymera Therapeutics. But when comparing it to its historical volatility, Chevron Corp is 3.19 times less risky than Kymera Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 3,338 in Kymera Therapeutics on September 1, 2024 and sell it today you would earn a total of 1,347 from holding Kymera Therapeutics or generate 40.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Chevron Corp vs. Kymera Therapeutics
Performance |
| Timeline |
| Chevron Corp |
| Kymera Therapeutics |
Chevron Corp and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chevron Corp and Kymera Therapeutics
The main advantage of trading using opposite Chevron Corp and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chevron Corp position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Chevron Corp vs. Shell PLC ADR | Chevron Corp vs. BP PLC ADR | Chevron Corp vs. Equinor ASA ADR | Chevron Corp vs. Petrleo Brasileiro SA |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |